Drugs that contain Tafluprost

1. List of Zioptan drug patents

ZIOPTAN's oppositions filed in EPO
ZIOPTAN Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US5886035 AKORN Difluoroprostaglandin derivatives and their use
Dec, 2022

(3 months ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10864159 AKORN Method and composition for treating ocular hypertension and glaucoma
May, 2029

(6 years from now)

US9999593 AKORN Method and composition for treating ocular hypertension and glaucoma
May, 2029

(6 years from now)

Market Authorisation Date: 10 February, 2012

Treatment: Reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension

Dosage: SOLUTION/DROPS;OPHTHALMIC

How can I launch a generic of ZIOPTAN before it's patent expiration?
More Information on Dosage

ZIOPTAN family patents

8

Japan

6

European Union

5

Korea, Republic of

4

Denmark

4

Slovenia

4

United States

4

Croatia

4

Portugal

4

Spain

4

Poland

3

Lithuania

3

Hungary

2

Argentina

2

Cyprus

2

Canada

1

Mexico

1

Australia

1

Jordan

1

Singapore

1

Brazil

1

Malaysia

1

Taiwan, Province of China

1

China

1

Georgia

1

Ukraine

EA

1

EA

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic